The VIDAS® ToRC panel includes 9 automated tests for the screening and diagnosis of toxoplasmosis, rubella and cytomegalovirus (CMV) infections.
The VIDAS® ToRC panel is a complete solution for the diagnosis and follow-up of the most important materno-fetal infections in pregnant women and newborns. Toxoplasmosis, Rubella and Cytomegalovirus (ToRC) infections are generally benign diseases. However when women are infected during pregnancy, consequences for the fetus can be dramatic. Our value-added IgG avidity tests help distinguish between recent and past infection, thus reducing the number of amniocenteses, and avoiding unnecessary treatment and stress for the future mothers.
A complete solution:
IgG: IgGs are widely used to determine the presence of specific immunity.
IgM: If IgMs appear earlier than IgGs, they also disappear earlier. This makes IgMs an early and sensitive marker of acute infection.
IgG avidity:
IgGs are initially of low avidity, but will mature to high avidity a few months after primary infection. A high IgG avidity index thus allows to rule out recently-acquired infection.